AG 18
Latest Information Update: 13 Nov 2002
Price :
$50 *
At a glance
- Originator Nonindustrial source
- Class Antipsoriatics; Tyrphostins
- Mechanism of Action DNA topoisomerase I inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer; Psoriasis